 Home > Medical News > Latest Medical News > Tengsheng Biopharmaceuticals and Sinopharm reached a cooperation to jointly commercialize the new crown neutralizing antibody

Tengsheng Biopharmaceuticals and Sinopharm reached a cooperation to jointly commercialize the new crown neutralizing antibody

 Last Update: 2022-05-26
 Source: Internet
 Author: User

Tags

trileptal half life

long effects benadryl

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Cube Info

On March 30, Tengsheng Biopharma announced that its subsidiary Tengsheng Huachuang had reached a strategic cooperation with Sinopharm Holding, and the two parties will work together to promote the company's long-acting new crown monoclonal neutralizing antibody ambavirumab/romisevirumab The commercialization process of combination therapy in China, including drug storage, channel distribution, regional access, and other innovative business cooperation

On December 8, 2021, the combination therapy of ambavirumab/romisevirumab was approved by the National Medical Products Administration (NMPA) for the treatment of mild and common patients with progression to severe (including hospitalization or death) ) adult and adolescent (12-17 years old, body weight ≥40 kg) patients with novel coronavirus infection (COVID-19) with high risk factors

Ambavirumab and romisevirumab are non-competitive novel severe acute respiratory infections obtained by Tengsheng Biopharmaceuticals in cooperation with Shenzhen Third People's Hospital and Tsinghua University from patients with novel coronavirus pneumonia (COVID-19) during the recovery period.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.